# Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

> **NCT01511549** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 24 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** placebo
- **DRUG:** SAR113945

## Key facts

- **NCT ID:** NCT01511549
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511549, "Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01511549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*